Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19.
Marios TomazouMarilena M. BourdakouGeorge MinadakisMargarita ZachariouAnastasis OulasEvangelos KaratzasEleni M. LoizidouAndrea C. KakouriChristiana C. ChristodoulouKyriaki SavvaMaria ZantiAnna OnisiforouSotiroula AfxentiJan RichterChristina G. ChristodoulouTheodoros C. KyprianouGeorge KoliosNikolas DietisGeorge M. SpyrouPublished in: Briefings Bioinform. (2021)